min. lectura
Dr. Bahey Salem was invited to join the Therapeutic Advances in Childhood Leukemia and Lymphoma (TACL) Immune Effector Cell Therapy Working Group, which is helping to advance therapies for incurable childhood leukemias and lymphomas.
Related Stories
81316
Awards
article